Historical Stock Price
ONCE historical stock prices picture
ONCE (ONCE) has the following price history information. Looking back at ONCE historical stock prices for the last five trading days, on December 11, 2019, ONCE opened at $111.52, traded as high as $112.00 and as low as $110.88, and closed at $110.91. Trading volume was a total of 434.10K shares. On December 12, 2019, ONCE opened at $110.81, traded as high as $111.24 and as low as $110.27, and closed at $110.55. Trading volume was a total of 681.40K shares. On December 13, 2019, ONCE opened at $110.57, traded as high as $111.30 and as low as $110.02, and closed at $110.75. Trading volume was a total of 770.40K shares. On December 16, 2019, ONCE opened at $113.85, traded as high as $113.90 and as low as $113.47, and closed at $113.57. Trading volume was a total of 2.51M shares. On December 17, 2019, ONCE opened at $113.57, traded as high as $113.57 and as low as $113.57, and closed at $113.57. Trading volume was a total of 23.90K shares.

ONCE Historical Stock Prices By Date:

ONCE historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ONCE shares, starting with a $10,000 purchase of ONCE, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/03/2015
End date: 12/17/2019
Start price/share: $45.98
End price/share: $113.57
Dividends collected/share: $0.00
Total return: 147.00%
Average Annual Total Return: 20.40%
Starting investment: $10,000.00
Ending investment: $24,703.04
Years: 4.87
Date Open High Low Close Volume
12/11/2019 $111.52 $112.00 $110.88 $110.91 434.10K
12/12/2019 $110.81 $111.24 $110.27 $110.55 681.40K
12/13/2019 $110.57 $111.30 $110.02 $110.75 770.40K
12/16/2019 $113.85 $113.90 $113.47 $113.57 2.51M
12/17/2019 $113.57 $113.57 $113.57 $113.57 23.90K
Spark Therapeutics is engaged in the field of gene therapy. Co. has built a pipeline of gene therapy product candidates that are directed to the retina, the liver and the central nervous system. Co.'s product, LUXTURNA™ (voretigene neparvovec-rzyl), has been approved by the U.S. Food and Drug Administration for the treatment of patients with viable retinal cells and confirmed biallelic RPE65 mutation-associated retinal dystrophy. Co.'s gene therapy product candidates in clinical development include: SPK-8011, Co.'s primary product candidate in the SPK-FVIII program for hemophilia A; SPK-8016, a product candidate for the hemophilia A inhibitor market; and SPK-7001, targeting choroideremia.
Date Close
12/11/2019$110.91
12/12/2019$110.55
12/13/2019$110.75
12/16/2019$113.57
12/17/2019$113.57
ONCE is categorized under the Healthcare sector; below are some other companies in the same sector:

ONCS Historical Stock Prices
ONCY Historical Stock Prices
ONS Historical Stock Prices
ONSIU Historical Stock Prices
ONSIZ Historical Stock Prices
ONTX Historical Stock Prices
ONTY Historical Stock Prices
ONVO Historical Stock Prices
ONXX Historical Stock Prices
OPGN Historical Stock Prices

Also explore: ONCE shares outstanding history

Email EnvelopeFree ONCE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ONCE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.